Use of LC-MS/MS to Identify Matrilysin/Matrix Metalloproteinase-7(MMP7) Cleavage Products of Perlecan (PLN)/Heparan Sulfate Proteoglycan (HSPG2)

Por Grindel, B.J., Chung, L.W., Farach-Carson, M.C., Pennington, Christopher
Publicado em 2013

Prostatic carcinogenesis evoked by cellular interaction.

Por Chung, L W, Chang, S M, Bell, C, Zhau, H, Ro, J Y, von Eschenbach, A C
Publicado em 1988

Can cancer cells transform normal host cells into malignant cells?

Por Pathak, S., Nemeth, M. A., Multani, A. S., Thalmann, G. N., von Eschenbach, A. C., Chung, L. W.
Publicado em 1997

Genetic changes associated with the acquisition of androgen-independent growth, tumorigenicity and metastatic potential in a prostate cancer model.

Por Hyytinen, E. R., Thalmann, G. N., Zhau, H. E., Karhu, R., Kallioniemi, O. P., Chung, L. W., Visakorpi, T.
Publicado em 1997

Matrilysin/Matrix Metalloproteinase-7(MMP7) Cleavage of Perlecan/HSPG2 Creates A Molecular Switch to Alter Prostate Cancer Cell Behavior

Por Grindel, B.J., Martinez, J.R., Pennington, C.L., Muldoon, M., Stave, J., Chung, L.W., Farach-Carson, M.C.
Publicado no Matrix Biol (2014)

Fibroblast-mediated acceleration of human epithelial tumor growth in vivo.

Por Camps, J L, Chang, S M, Hsu, T C, Freeman, M R, Hong, S J, Zhau, H E, von Eschenbach, A C, Chung, L W
Publicado em 1990